The Use of Radioactive Marker as a Tool to Evaluate the Drug Release in Plasma and Particle Biodistribution of Block Copolymer Nanoparticles

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Polymers</td><td align="center">Size nm (diameter)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">PEG2.5-PS3K</td><td align="center">16.3</td></tr><tr><td align="left">PLA3.9K-PEG2K</td><td align="center">9.3</td></tr><tr><td align="left">PCL6K-PEG5K</td><td align="center">18.9</td></tr><tr><td align="left">DSPE2K-PEG</td><td align="center">10</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Stabilisers <sup>3</sup>[H] CHE-labelled nanoparticles.

Journal of Drug Delivery

tab1

Table 1

Table 1: The Use of Radioactive Marker as a Tool to Evaluate the Drug Release in Plasma and Particle Biodistribution of Block Copolymer Nanoparticles 

Table 1 | The Use of Radioactive Marker as a Tool to Evaluate the Drug Release in Plasma and Particle Biodistribution of Block Copolymer Nanoparticles 